Back to User profile » Dr Yuan-Jie Liu

Papers published by Dr Yuan-Jie Liu:


An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC)

Huang P, Hu YD, Liu YJ, Li JP, Zhang YH

Journal of Hepatocellular Carcinoma 2023, 10:959-978

Published Date: 22 June 2023

An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)

Huang W, Mei J, Liu YJ, Li JP, Zou X, Qian XP, Zhang Y

Journal of Hepatocellular Carcinoma 2023, 10:497-515

Published Date: 30 March 2023

Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma

Sha Y, Mao AQ, Liu YJ, Li JP, Gong YT, Xiao D, Huang J, Gao YW, Wu MY, Shen H

Pharmacogenomics and Personalized Medicine 2023, 16:153-172

Published Date: 4 March 2023

Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis

Yin Y, Xu ZY, Liu YJ, Huang W, Zhang Q, Li JP, Zou X

Journal of Hepatocellular Carcinoma 2022, 9:885-900

Published Date: 27 August 2022

USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma

Zhang Q, Liu YJ, Li JP, Zeng SH, Shen H, Han M, Guo S, Liu SL, Zou X

Journal of Inflammation Research 2022, 15:3065-3082

Published Date: 24 May 2022

An Analysis Regarding the Association Between Connexins and Colorectal Cancer (CRC) Tumor Microenvironment

Liu YJ, Han M, Li JP, Zeng SH, Ye QW, Yin ZH, Liu SL, Zou X

Journal of Inflammation Research 2022, 15:2461-2476

Published Date: 15 April 2022

DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma

Liu YJ, Zeng SH, Qian WH, Tao MX, Zhu YY, Li JP

Pharmacogenomics and Personalized Medicine 2022, 15:261-275

Published Date: 24 March 2022

DZIP1 Expression as a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis

Liu YJ, Li JP, Zeng SH, Han M, Liu SL, Zou X

Pharmacogenomics and Personalized Medicine 2021, 14:1151-1168

Published Date: 16 September 2021

A Serum Metabolomic Study Reveals Changes in Metabolites During the Treatment of Lung Cancer-Bearing Mice with Anlotinib

Pan X, Chen W, Nie M, Liu Y, Xiao Z, Zhang Y, Zhang W, Zou X

Cancer Management and Research 2021, 13:6055-6063

Published Date: 4 August 2021

FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration

Liu YJ, Li JP, Zhang Y, Nie MJ, Zhang YH, Liu SL, Zou X

OncoTargets and Therapy 2021, 14:4099-4117

Published Date: 6 July 2021